Search hospitals > Oregon > Portland
Providence Saint Vincent Medical Center
Claim this profilePortland, Oregon 97225
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Cervical Adenocarcinoma
485 reported clinical trials
25 medical researchers
Summary
Providence Saint Vincent Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Cancer, Lung Cancer, Cervical Adenocarcinoma and other specialties. Providence Saint Vincent Medical Center is involved with conducting 485 clinical trials across 632 conditions. There are 25 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cystic Tumor
53 reported clinical trials
99 drugs studied
Rachel Sanborn, MDProvidence Portland Medical Center5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
43 reported clinical trials
68 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
28 reported clinical trials
79 drugs studied
Clinical Trials running at Providence Saint Vincent Medical Center
Breast Cancer
Lung Cancer
Breast cancer
Parotid Gland Cancer
Cancer
Multiple Myeloma
Prostate Cancer
Ovarian Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Providence Saint Vincent Medical Center?
Where is Providence Saint Vincent Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Providence Saint Vincent Medical Center accept?
What awards or recognition has Providence Saint Vincent Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.